WallStreetZen

NYSE: BMY
Bristol Myers Squibb Co Stock Forecast, Predictions & Price Target

Analyst price target for BMY

Based on 6 analysts offering 12 month price targets for Bristol Myers Squibb Co.
Min Forecast
$62.00-8.65%
Avg Forecast
$70.83+4.37%
Max Forecast
$76.00+11.98%

Should I buy or sell BMY stock?

Based on 6 analysts offering ratings for Bristol Myers Squibb Co.
Buy
Strong Buy
3 analysts 50%
Buy
0 analysts 0%
Hold
3 analysts 50%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

BMY stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDate
Truist Securities
Top 21%
80
Strong BuyUpgrades$74.00+9.03%2021-04-13
Societe Generale
Bottom 33%
33
Strong BuyUpgrades$76.00+11.98%2020-11-16
Guggenheim
Bottom 4%
4
Strong BuyUpgrades$70.00+3.14%2020-10-19
Morgan Stanley
Top 17%
84
HoldMaintains$71.00+4.61%2021-07-29
Morgan Stanley
Top 27%
74
HoldDowngrades$62.00-8.65%2021-04-30
Anonymous
Bernstein
HoldReinstates$72.00+6.09%2020-11-10

1 of 1

Forecast return on equity

Is BMY forecast to generate an efficient return?
Company
52.6%
Industry
73.39%
Market
59.49%
BMY's Return on Equity is forecast to be high in 3 years (52.6%); analysts are confident in the firm's ability to efficiently generate return on equity
Forecast

Forecast return on assets

Is BMY forecast to generate an efficient return on assets?
Company
17.48%
Industry
16.5%
Market
15.35%
BMY is forecast to generate higher Return on Assets (17.48%) than the US Drug Manufacturers - General industry average (16.5%)
Forecast

BMY earnings per share forecast

What is BMY's earnings per share in the next 3 years based on estimates from 7 analysts?
Avg 1 year Forecast
$7.43-431.7%
Avg 2 year Forecast
$8.06-459.6%
Avg 3 year Forecast
$8.49-479.02%

BMY revenue forecast

What is BMY's revenue in the next 3 years based on estimates from 5 analysts?
Avg 1 year Forecast
$45.9B+3.39%
Avg 2 year Forecast
$47.8B+7.69%
Avg 3 year Forecast
$49.5B+11.49%
BMY's revenue is forecast to grow at a rate of 3.69% per year, which is not exceptional
Forecast

BMY revenue growth forecast

How is BMY forecast to perform vs Drug Manufacturers - General companies and vs the US market?
Company
3.69%
Industry
5.1%
Market
13.54%
BMY's revenues are forecast to grow slower (3.69% per year) than the US Drug Manufacturers - General industry average (5.1%)
Forecast
BMY's revenues are forecast to grow slower (3.69% per year) than the US market average (13.54%)
Forecast

Bristol Myers Squibb Stock Forecast FAQ

Is Bristol Myers Squibb Stock a good buy in 2021, according to Wall Street analysts?

The consensus among 6 Wall Street analysts covering (NYSE: BMY) stock is to Buy BMY stock.

Out of 6 analysts, 3 (50%) are recommending BMY as a Strong Buy, 0 (0%) are recommending BMY as a Buy, 3 (50%) are recommending BMY as a Hold, 0 (0%) are recommending BMY as a Sell, and 0 (0%) are recommending BMY as a Strong Sell.

What is BMY's earnings growth forecast for 2021-2023?

(NYSE: BMY) Bristol Myers Squibb's forecast annual earnings growth rate of N/A is not forecast to beat the US Drug Manufacturers - General industry's average forecast earnings growth rate of 29.46%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 18.23%.

Bristol Myers Squibb's earnings in 2021 is -$5,079,000,000.On average, 7 Wall Street analysts forecast BMY's earnings for 2021 to be $16,510,303,699, with the lowest BMY earnings forecast at $16,376,976,886, and the highest BMY earnings forecast at $16,665,851,648. On average, 8 Wall Street analysts forecast BMY's earnings for 2022 to be $17,899,124,669, with the lowest BMY earnings forecast at $17,376,927,984, and the highest BMY earnings forecast at $18,443,542,490.

In 2023, BMY is forecast to generate $18,865,744,065 in earnings, with the lowest earnings forecast at $18,065,783,186 and the highest earnings forecast at $19,932,358,570.

What is BMY's revenue growth forecast for 2021-2023?

(NYSE: BMY) Bristol Myers Squibb's forecast annual revenue growth rate of 3.69% is not forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 5.1%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.54%.

Bristol Myers Squibb's revenue in 2021 is $44,384,000,000.On average, 5 Wall Street analysts forecast BMY's revenue for 2021 to be $101,972,253,195,690, with the lowest BMY revenue forecast at $100,457,976,138,090, and the highest BMY revenue forecast at $103,343,835,009,371. On average, 5 Wall Street analysts forecast BMY's revenue for 2022 to be $106,207,303,864,492, with the lowest BMY revenue forecast at $104,558,575,604,254, and the highest BMY revenue forecast at $107,844,726,010,973.

In 2023, BMY is forecast to generate $109,957,164,927,451 in revenue, with the lowest revenue forecast at $108,127,267,749,236 and the highest revenue forecast at $112,302,285,798,291.

What is BMY's forecast return on assets (ROA) for 2021-2024?

(NYSE: BMY) forecast ROA is 17.48%, which is higher than the forecast US Drug Manufacturers - General industry average of 16.5%.

What is BMY's Price Target?

According to 6 Wall Street analysts that have issued a 1 year BMY price target, the average BMY price target is $70.83, with the highest BMY stock price forecast at $76.00 and the lowest BMY stock price forecast at $62.00.

On average, Wall Street analysts predict that Bristol Myers Squibb's share price could stay at $70.83 by Jul 29, 2022. The average Bristol Myers Squibb stock price prediction forecasts a potential downside of N/A from the current BMY share price of $67.87.

What is BMY's Earnings Per Share (EPS) forecast for 2021-2023?

(NYSE: BMY) Bristol Myers Squibb's current Earnings Per Share (EPS) is -$2.24. On average, analysts forecast that BMY's EPS will be $7.43 for 2021, with the lowest EPS forecast at $7.37, and the highest EPS forecast at $7.50. On average, analysts forecast that BMY's EPS will be $8.06 for 2022, with the lowest EPS forecast at $7.82, and the highest EPS forecast at $8.30. In 2023, BMY's EPS is forecast to hit $8.49 (min: $8.13, max: $8.97).

What is BMY's forecast return on equity (ROE) for 2021-2024?

(NYSE: BMY) forecast ROE is 52.6%, which is considered strong.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.